Henry S. Kaplan
Affiliations: | Radiology | Stanford University, Palo Alto, CA |
Area:
Radiotherapy, CancerWebsite:
https://en.wikipedia.org/wiki/Henry_Kaplan_(physician)Google:
"Henry Seymour Kaplan"Bio:
(1918 - 1984)
http://www.nasonline.org/member-directory/deceased-members/53979.html
https://pubs.rsna.org/doi/abs/10.1148/radiology.152.3.830-a?journalCode=radiology
Mean distance: (not calculated yet)
Cross-listing: Imaging Tree - MPROTree
Children
Sign in to add trainee| Eli Glatstein | research assistant | Stanford (MPROTree) | |
| Stephen E. Jones | grad student | Stanford University Medical School (MPROTree) | |
| Ohtsura Niwa | grad student | 1975 | Stanford (Cell Biology Tree) |
| Irving L. Weissman | research scientist | Stanford (FlyTree) | |
| Malcolm Bagshaw | research scientist | 1956-1996 | Stanford University Medical School (MPROTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rivkin S, Moon J, Iriarte D, et al. (2017) Abstract AP30: PHASE IB/II WITH EXPANSION OF PATIENTS AT THE MTD STUDY OF OLAPARIB PLUS WEEKLY (METRONOMIC) CARBOPLATIN AND PACLITAXEL IN RELAPSED OVARIAN CANCER PATIENTS Clinical Cancer Research. 23 |
| de Vos S, Forero-Torres A, Ansell SM, et al. (2014) A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. Journal of Hematology & Oncology. 7: 44 |
| Kaplan H, Malmgren J, Atwood M. (2009) Myelodysplastic Syndrome and Acute Myeloid Leukemia Incidence Following Primary Breast Cancer Treatment. Cancer Research. 69: 2082-2082 |
| Kaplan H, Malmgren J, Atwood M, et al. (2009) Response Rates to Neoadjuvant Cyclophosphamide and Doxorubicin (AC) in Breast Cancer Patients Exhibiting Her-2/Neu (Her-2) Negative, Topoisomerase II (TOPO 2A) Normal, Chromosome 17 (C17) Normal Phenotype. Cancer Research. 69: 2033-2033 |
| Advani R, Vos SD, Ansell SM, et al. (2008) A Phase 2 Clinical Trial of SGN-40 Monotherapy in Relapsed Diffuse Large B-Cell Lymphoma. Blood. 112: 1000-1000 |
| Johnson DW, Hoppe RT, Cox RS, et al. (2006) Hodgkin's disease limited to intrathoracic sites Cancer. 52: 8-13 |
| Taylor MA, Kaplan HS, Nelsen TS. (1985) Staging laparotomy with splenectomy for Hodgkin's disease: the Stanford experience. World Journal of Surgery. 9: 449-460 |
| Herman TS, Hoppe RT, Donaldson SS, et al. (1985) Late Relapse Among Patients Treated for Hodgkin's Disease Annals of Internal Medicine. 102: 292-297 |
| Rosenberg SA, Kaplan HS. (1985) The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984 International Journal of Radiation Oncology, Biology, Physics. 11: 5-22 |
| Martinez A, Goffinet DR, Donaldson SS, et al. (1985) Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma International Journal of Radiation Oncology Biology Physics. 11: 123-128 |